![]() |
市场调查报告书
商品编码
1224691
美国独立诊断实验室市场规模,份额和趋势分析报告:按服务分类(放射学/影像服务,心臟监测服务,睡眠研究),细分市场预测2023-2030U.S. Independent Diagnostic Testing Facility Market Size, Share & Trends Analysis Report By Service (Radiology/Imaging Services, Cardiac Monitoring Services, Sleep Studies), And Segment Forecasts, 2023 - 2030 |
美国独立诊断实验室市场的增长和趋势
根据 Grand View Research, Inc. 的最新报告,美国独立诊断实验室市场规模预计从 2023 年到 2030 年将以 4.52% 的复合年增长率增长,到 2030 年将达到 48 亿美元。 心血管疾病等目标疾病的患病率上升,以及对疾病早期检测和监测诊断测试的需求不断增长,预计将推动市场增长。
此外,患者对疾病早期发现意识的提高预计也将有利于市场增长。 由于独立诊断实验室 (IDFT) 的诊断程序成本较低,患者数量正在从医院转移到 IDFT。 CMS 私人付款人最近的站点中立支付政策增加了对 IDTF 成像量的需求。
由于严重的监管关闭和患者数量的急剧下降,COVID-19 大流行对新兴的独立诊断实验室市场产生了重大影响。 大流行后患者随着对影像服务的需求从医院转向门诊诊断,促进了市场的增长。
美国独立诊断实验室市场报告要点
到 2022 年,由于诊断成像在疾病早期有效检测方面的应用越来越多,放射/成像服务部门的收入份额最大。
由于人们越来越意识到睡眠时间减少和睡眠障碍对健康的影响,以及该国急性健康问题的流行率上升,预计睡眠测试部分在预测期内将出现显着增长。
在美国,IDTF 的监管和报销情况正在发生变化,从而使 IDTF 能够在不太严格的监管下提供服务。 例如,2021 年 12 月,医疗保险和医疗补助服务中心 (CMS) 豁免了进行非面对面,间接测试的 IDTF 符合410.33(g) 中规定的 IDTF 计划完整性要求
併购和产品开发是市场参与者追求的一些主要战略。 例如,2021 年 2 月,CB Scientific, Inc. 签订了收购 Cardiolink Corporation 的最终协议,Cardiolink Corporation 是一家总部位于纽约的 Medicare 认证的 IDTF。
The U.S. independent diagnostic testing facility market size is expected to reach USD 4.8 billion by 2030, expanding at a CAGR of 4.52% from 2023 to 2030, based on a new report by Grand View Research, Inc. Growing prevalence of target diseases such as cardiovascular diseases coupled with rising demand for early disease detection and monitoring diagnostic tests are expected to drive the market growth.
Furthermore, rising awareness among patients regarding the early detection of diseases is anticipated to favor market growth. The lower cost of performing diagnostic procedures at independent diagnostic testing facilities (IDTFs) has shifted patient volumes from hospitals to IDTFs. The site-neutral payment policies from CMS private payors in recent times have boosted the demand for imaging volumes to the IDTFs.
The COVID-19 pandemic has significantly impacted the independent diagnostic testing facilities market during the initial period, owing to the closure of services and the sharp decline in patient volumes due to stringent regulations. Post-pandemic patients are shifting from hospital settings to outpatient settings for diagnosis with the demand for imaging diagnostics services, contributing to the growth of the market.